Prudential Financial
SGNT

Prudential Financial’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Prudential Financial’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-240,659
Closed -$3.6M – 2382
2016
Q2 		$3.6M Sell
240,659
-24,940
-9% -$320K 0.01% 1272
2016
Q1 		$3.23M Buy
265,599
+31,200
+13% +$438K 0.01% 1327
2015
Q4 		$3.73M Buy
234,399
+47,900
+26% +$754K 0.01% 1211
2015
Q3 		$2.86M Buy
186,499
+135,283
+264% +$2.92M 0.01% 1291
2015
Q2 		$1.25M Buy
51,216
+600
+1% +$14.4K ﹤0.01% 1748
2015
Q1 		$1.18M Sell
50,616
-5,100
-9% -$135K ﹤0.01% 1773
2014
Q4 		$1.4M Sell
55,716
-30,450
-35% -$893K ﹤0.01% 1622
2014
Q3 		$2.68M Buy
86,166
+40,806
+90% +$1.11M 0.01% 1261
2014
Q2 		$1.17M Buy
+45,360
New +$1.01M ﹤0.01% 1763

Prudential Financial's SGNT Position: Q3 2016 in Review

Prudential Financial sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 240,659 shares — an estimated $3.6M sold.

Prudential Financial first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $3.73M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Prudential Financial reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Prudential Financial sold 240,659 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $3.6M.
  • Prudential Financial first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • Prudential Financial's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.73M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Prudential Financial's 13F filing for Q3 2016, filed 4 Nov 2016.